Allahabad HC refuses to quash case against pharma company linked to cough syrup deaths in Uzbekistan

Allahabad:  The Allahabad High Court recently declined to quash proceedings under the Drugs and Cosmetics Act against the directors of a company accused of manufacturing sub-standard cough syrup that caused…

IPC registers 44 small-scale medtech firms under ADRMS

Mumbai: The Indian Pharmacopoeia Commission (IPC) has registered 44 small-scale medtech firms under ADR Monitoring System (ADRMS) to help them report medical devices related serious adverse events (SAEs) for patient and…

Over 9,000 deaths due to respiratory diseases in Delhi

New Delhi:  The national capital recorded 9,211 deaths due to respiratory diseases in 2024, up from 8,801 in 2023, continuing an upward trend seen over the past few years, according…

Nebuliser, inhaler demand for children jumps by up to 60 pc in Delhi winters: Survey

New Delhi:  The demand for nebulisers, inhalers and respiratory medicines for children has surged sharply in Delhi during winter months, with chemists reporting spikes of up to 60 per cent…

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Hyderabad: While most people know that a dog bite requires immediate medical attention, a critical detail that is often overlooked is where exactly should the injection be administered? People should…

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…

DoP may exempt 11 more drugs from public procurement rules

New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…

DoP calls for proposals to set up common facilities for medical device clusters

New Delhi: The Department of Pharmaceuticals (DoP) has invited applications from eligible stakeholders to set up common facilities for medical device clusters in the country, under the scheme for Strengthening…